top of page

The Latest
News and Updates from Americans for Safe Drugs and the Pharma Industry

Generic Drugs Maker Intas Pharmaceuticals Keeps Failing Inspections
Intas received 16 “observations” on their Form 483 inspection report.
Jul 13, 20233 min read
38 views
0 comments

At India Drug Maker Aurobindo Lab, FDA Finds “Deficient” Manufacturing Equipment
America’s drug supply is increasingly reliant on companies who continually get failing grades from the Food & Drug Administration.
Jun 30, 20233 min read
41 views
0 comments


FDA Allows Uninspected China Lab to Sell Cancer Drugs in the US
“We can’t risk patients' lives by giving them potentially bad drugs from unapproved manufacturers."
Jun 9, 20233 min read
36 views
0 comments


Notorious India Drug Maker Intas Pharmaceuticals Gets FDA Import Alert, But Allowed to Export to US
An import alert means the lab’s products are off limits to the U.S. until corrections are made to its manufacturing processes.
Jun 9, 20233 min read
34 views
0 comments

FDA Considers Allowing Cancer Drug Imports from Unapproved Foreign Manufacturers
Shocking Decision Risks Patients Lives Battling Cancer WASHINGTON — Americans for Safe Drugs, a campaign led by the Coalition for a...
Jun 2, 20233 min read
74 views
0 comments


India-Based Contract Drug Manufacturer Astral SteriTech Recalls Medications
The recall was being initiated because of failures in environmental monitoring of the facility where the drugs are made.
May 19, 20233 min read
398 views
0 comments

Why Is The FDA Slacking On Foreign Lab Inspections?
New Report Shows FDA Inspected Just 6% of Drug Manufacturers By some estimates, well over half of America’s generic drug supply comes...
May 2, 20233 min read
8 views
0 comments

FDA Allowing Banned Indian Drug Manufacturer to Export Drugs to the United States
Americans at Risk of Taking Potentially Unsafe Drug from Facility Under FDA Import Ban WASHINGTON — Americans for Safe Drugs today...
Feb 2, 20232 min read
338 views
0 comments
bottom of page